SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 21.95
+0.15 (0.69%)
At close: Aug 14, 2026
ETR:1SXP Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, ETR:1SXP stock has a consensus rating of "Buy" and an average price target of €21.69. The average 1-year stock price forecast is 1.18% lower than the current stock price, while the lowest is €13.00 (-40.77%) and the highest is €27.00 (+23.01%).
Price Target: €21.69 (-1.18%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ETR:1SXP stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
1.04B
from 986.21M
Increased by 5.42%
Revenue Next Year
1.10B
from 1.04B
Increased by 5.35%
EPS This Year
0.99
from 0.97
Increased by 1.80%
EPS Next Year
1.08
from 0.99
Increased by 9.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.